VAERS reports by lot

GSK Varicella/Shingles lot 32ZG4: VAERS reports

53 VAERS reports list lot 32ZG4 as a GSK Varicella/Shingles vaccine, received between 2019-01-24 and 2020-12-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
53
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5828%
Injection-site / Local reaction4120%
Dermatological (non-injection-site)2914%
Neurological2110%
Allergic / Anaphylactic178%
Musculoskeletal168%
Cardiac / Cardiovascular94%
Respiratory52%
Gastrointestinal42%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
California6
Washington5
Massachusetts4
Pennsylvania3
North Carolina3
Florida3
Minnesota2
Kentucky2
Alabama2
Vermont2
New York2

Reports by month received

2019-015
2019-0220
2019-039
2019-0410
2019-053
2019-072
2019-081
2019-092
2020-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.